Tcr2 Therapeutics Overview

Tcr2 Therapeutics Other Income Expense Net

Other Income/Expense Net for TCRR.

Quarterly Other Income/Expense

$1.11M

↑ 849.57% YoY

As of Mar 31, 2023

Annual Other Income/Expense (TTM)

$2.93M

↑ 1203.11% YoY

Trailing 12 months ending Mar 31, 2023

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin